Remedium Bio: Funding, Investors & Team (Sep 2026)
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe conditions. Our strategy for product development involves using established technologies in innovative ways to target well-understood disease processes. We aim to simplify our research by incorporating successful elements of technology to create localized treatments that concentrate on proven molecules and pathways. Our current focus is on gene therapy for Rheumatology / Osteoarthritis, Endocrinology / Diabetes, and Neurology / Stroke.
Remedium Bio has raised $13.8M across 5 funding rounds on record, the most recent a Series A of $10.0M announced in Aug 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Remedium Bio Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Remedium Bio Funding Rounds
2 of 5 rounds were announced without a disclosed amount and are excluded from the total.
Remedium Bio raised $2.3M in a Seed announced in Aug 2022.
1 years later, an undisclosed round was announced in Aug 2023 with no disclosed amount.
1.1 years later, a Seed was announced in Sep 2024 with no disclosed amount.
1.7 years later, an undisclosed round of $1.5M was announced in May 2026.
3 months later, a Series A of $10.0M was announced in Aug 2026.
Remedium Bio Investors
12 investors are recorded in total; the 5 named above are those the record identifies.
Remedium Bio Founders and Leadership Team
Contact details for the Remedium Bio team: 3 of 4 have an email address on file, 3 have a LinkedIn profile.
Start 14-day free trial →Remedium Bio Funding Compared to Other Biotechnology Startups
Remedium Bio's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Remedium Bio in Biotechnology and Needham
Companies Similar to Remedium Bio
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in…
Remedium Bio Funding FAQs
What does Remedium Bio do?
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe conditions. Our strategy for product development involves using established technologies in innovative ways to target well-understood disease processes. We aim to simplify our research by incorporating successful elements of technology to create localized treatments that concentrate on proven molecules and pathways. Our current focus is on gene therapy for Rheumatology / Osteoarthritis, Endocrinology / Diabetes, and Neurology / Stroke.
How much funding has Remedium Bio raised?
Remedium Bio has raised $13.8M across 5 rounds on record. The most recent is a Series A of $10.0M announced in Aug 2026.
When did Remedium Bio last raise funding?
Remedium Bio's most recent funding round on record is a Series A of $10.0M, announced in Aug 2026.
Who has invested in Remedium Bio?
Investors on record for Remedium Bio include Eli Lilly, National Science Foundation, Ulu Ventures, MicroVentures, Longevitytech.fund. FundedIQ records 12 investors in total.
Who founded Remedium Bio?
FundedIQ lists Francesco Luppino (Founder), Luppino (Founder) at Remedium Bio.
Who is the CEO of Remedium Bio?
Frank Luppino is listed as CEO at Remedium Bio.
Where is Remedium Bio headquartered?
Remedium Bio is based in Needham, Massachusetts, United States.
How many employees does Remedium Bio have?
Remedium Bio is in the 1-10 employee band.
When was Remedium Bio founded?
Remedium Bio was founded in 2020.
How does Remedium Bio's funding compare to other Biotechnology startups?
Remedium Bio's latest round of $10.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Remedium Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Remedium Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.